This Government Contract opportunity from Department Of Defense was posted on May 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Supply of Reverse Blood Grouping Test Kits (Affirmagen)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the procurement and delivery of commercial off-the-shelf reverse blood grouping test kits, specifically designed to contain group A1 and B cells for confirming blood types. These test kits, identified as Affirmagen, are critical for medical procedures requiring accurate blood typing and compatibility testing. The Department of Defense's Medical Supply Chain MD Surg FSF is the contracting agency responsible for this subcontract. The solicitation, posted on May 27, 2026, seeks responses by June 2, 2026. The place of performance is Williamsburg, with the relevant NAICS code classified as 325414, indicating the manufacturing of biological products. This acquisition ensures a reliable supply of essential diagnostic test kits to support medical readiness and operational efficiency within the military healthcare system.
General Info
Agency
NAICS
Place of Performance
WILLIAMSBURG, VA, 23185-5830, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
